From
Brain Science to Full Vision

RevitalVision is used to improve vision in amblyopic adults as a standalone therapy and when patching is no longer effective! It is the only FDA approved treatment with efficacy claims for adult amblyopia age 9 and up!
Other amblyopia software programs are mostly used to treat children, when patching therapy may still be effective and are not indicated as a standalone therapy. They are indicated to be used in combination with patching in children.
Additional amblyopia software programs are used to treat convergence insufficiency.

No, RevitalVision uses unique perceptual learning technology, scientifically and clinically proven with randomized controlled double-blind studies, published in pear reviewed medical journals. Unlike binocular training programs, RevitalVision is FDA approved for adult amblyopia as a standalone therapy.

By improving the brain's visual processing to perform better than normal, it compensates for some blurry image caused by the small refractive error.

RevitalVision has no effect on patient refraction nor on patient accommodation capabilities. It enables patients with small refractive error to see better without correction despite of the small refractive error.

More than 20 clinical studies tested the efficacy of RevitalVision in different clinical indications, by different clinicians and in different countries (USA, Europe and Asia), all showing similar clinical outcome. 7 studies have been published in pear reviewed medical journals, 3 of them are randomized controlled studies. Most of the studies are available on our website.

Possible explanation of the improvement mechanism is the lack of prolonged effective cortical stimulation, caused by a blurred or damaged image transferred from the retina to the brain, results reduced cortical activity. Thus, in addition to the anatomical damage to the eye, there is secondary gradually-evolved damage to the quality of the image processing in the brain.
Similar to amblyopia, effective stimulation and perceptual learning process enables significant improvement in cortical activity, resulting in improved visual acuity and contrast sensitivity, despite the absence of any anatomical improvement or changes during the course of the disease.

85% of patients improve by 2 – 2.5 VA lines (in ETDRS/ LogMar) and 100% in contrast sensitivity (using FACT sine wave test), approximately 10% do not respond.

Yes, follow up of 1-2 years in clinical studies shows the improvement gained with RevitalVision remains. In fact, amblyopic patients demonstrate additional spontaneous improvement in CS and Stereo after 1 year from completing the program.
Just like learning to walk, riding a bicycle and learning to swim have a long-lasting effect, so does RevitalVision.

With the exception of Post Cataract and Sports Vision programs, all other programs require clinical examination and prescription.

RevitalVision training sessions are performed at the patient’s home. You can choose to offer patients a first in-clinic guided session or send them home to perform all the training sessions. It is for you to decide based on your clinic capacity and policy and on your patient’s ability.
The patient will be instructed to perform 3-4 home training sessions per week at home and come back to you for a follow-up exam at mid and post-program. In these appointments, you will measure the improvement in patients’ visual acuity, contrast sensitivity and stereo acuity & binocular functions in cases of amblyopia.

While a clinic purchase software licenses from our company, the patient buys a therapy program from the clinic.
The price value for patient therapy package includes: (1) Software license valid for 80 sessions or 1 year - the earliest (2) 3-4 eye/vision examinations - baseline + follow-ups, (3) In-clinic guided session-optional (4) Technical support through the license period (5) Training monitoring (6) Warranty. The price does not include new optical correction if needed.

There is no need to purchase any hardware and there are no advance payments for providers to use our technology. You only need to purchase a single patient use software license once you have a paying customer. You can also purchase bulk quantity to enjoy discounted prices.
Patient recommended price varies between countries based on economic development level. The price is built from the cost of the software to clinics plus additional costs of physician time.
For more information on pricing please contact your local RevitalVision distributor or the company directly if you do not have a local distributor.

The American Medical Association (AMA) has issued 2 unique CPT Codes for RevitalVision amblyopia therapy. The codes will be effective from January 22.
058XT - Treatment of amblyopia using an online digital program; device supply, educational setup, and initial session.
059XT - Assessment of patient performance and program data by physician or qualified health care professional, with the report, per calendar month

There is no cost to sign-up and it can be completed in a few minutes. Click the "Become a provider" button at the top of this page.
After your registration is complete, you will have immediate access to the Clinician’s Admin Portal where you will be able to manage your patients and purchase licenses.
There is no need to purchase hardware and there are no advance payments to use our technology.
Simply purchase a license as needed for your patient at the time of treatment or purchase bulk licenses in advance for added discounts.